Kulkarni S, Wilkinson I
Handb Exp Pharmacol. 2024; 285:297-332.
PMID: 38890192
DOI: 10.1007/164_2024_719.
Yaacoub S, Boudaka A, AlKhatib A, Pintus G, Sahebkar A, Kobeissy F
Mol Cell Biochem. 2024; 479(12):3255-3271.
PMID: 38424404
PMC: 11511726.
DOI: 10.1007/s11010-024-04947-9.
Tanaka N, Kawahira K, Kudo A, Kashima T, Tanaka H
Eur J Clin Pharmacol. 1982; 22(5):383-7.
PMID: 6288395
DOI: 10.1007/BF00542539.
Lubbe W
Drugs. 1984; 28(2):170-88.
PMID: 6147240
DOI: 10.2165/00003495-198428020-00005.
Man in t Veld A, SCHALEKAMP M
Br J Clin Pharmacol. 1982; 13(Suppl 2):245S-257S.
PMID: 6125175
PMC: 1402134.
DOI: 10.1111/j.1365-2125.1982.tb01922.x.
Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension.
Prichard B
Br J Clin Pharmacol. 1982; 13(1):51-60.
PMID: 6121573
PMC: 1401763.
DOI: 10.1111/j.1365-2125.1982.tb01336.x.
Adaptation of hypertensives to treatment with cardioselective and non-selective beta-blockers. Absence of correlation between bradycardia and blood pressure control, and reduction in slope of the QT/RR relation.
Williams E, Hassan M, Floras J, Sleight P, Jones J
Br Heart J. 1980; 44(5):473-87.
PMID: 6108122
PMC: 482432.
DOI: 10.1136/hrt.44.5.473.
Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
Weber M, Stokes G, Gain J
J Clin Invest. 1974; 54(6):1413-9.
PMID: 4154950
PMC: 301696.
DOI: 10.1172/JCI107888.
Renal effects of antihypertensive drugs.
Schlueter W, Batlle D
Drugs. 1989; 37(6):900-25.
PMID: 2667938
DOI: 10.2165/00003495-198937060-00005.
Effect of propranolol and prindolol on renin secretion in normal supine man.
Vetter W, ZARUBA K, Armbruster H, Beckerhoff R, Vetter H, Nussberger J
Klin Wochenschr. 1975; 53(15):709-11.
PMID: 1241067
DOI: 10.1007/BF01468701.
Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment.
Bianchetti G, Graziani G, Brancaccio D, Morganti A, Leonetti G, Manfrin M
Clin Pharmacokinet. 1976; 1(5):373-84.
PMID: 1017154
DOI: 10.2165/00003088-197601050-00004.
[Effect of the beta-receptor-blocker prindolol on renal hypertension (author's transl)].
Undeutsch K, Sieberth H, MEURER K
Klin Wochenschr. 1976; 54(22):1077-84.
PMID: 1003866
DOI: 10.1007/BF01469111.
The effect of pindolol on plasma renin activity and blood pressure in hypertensive patients.
Lancaster R, Goodwin T, Peart W
Br J Clin Pharmacol. 1976; 3(3):453-60.
PMID: 973972
PMC: 2958755.
DOI: 10.1111/j.1365-2125.1976.tb00621.x.
Mechanism of the interaction of propranolol and a potent vasodilator antihypertensive agent - minoxidil.
OMalley K, Velasco M, Wells J, McNay J
Eur J Clin Pharmacol. 1976; 09(5-6):355-60.
PMID: 971700
DOI: 10.1007/BF00606548.
[Behaviour of plasma renin activity during long-term treatment with propranolol (author's transl)].
WITZGALL H, Klaus D, Braun B, Ebel H, Zehner J
Klin Wochenschr. 1977; 55(7):351-3.
PMID: 870747
DOI: 10.1007/BF01488116.
Plasma concentrations of propranolol in patients with essential hypertension.
Lehtonen A, Kanto J, Kleimola T
Eur J Clin Pharmacol. 1977; 11(3):155-7.
PMID: 852494
DOI: 10.1007/BF00606403.
Effect of antihypertensive drugs on the renin-angiotensin system.
Johnston C
Drugs. 1976; 12(4):274-91.
PMID: 786609
DOI: 10.2165/00003495-197612040-00003.
Labetalol in severe and resistant hypertension.
Williams L, Murphy M, Parsons V
Br J Clin Pharmacol. 1979; 8(Suppl 2):143S-147S.
PMID: 526395
PMC: 1429737.
The effect of chronic oxprenolol therapy on blood prolactin, growth hormone, renin and aldosterone levels.
Lewis M, Wilton A, Groom G, Henderson A
Br J Clin Pharmacol. 1979; 8(3):279-81.
PMID: 497094
PMC: 1429795.
DOI: 10.1111/j.1365-2125.1979.tb01015.x.
Acebutolol in hypertension: relationships between drug concentration and effects.
Martin M, Phillips F, Tucker G, Smith A
Eur J Clin Pharmacol. 1978; 14(6):383-90.
PMID: 367793
DOI: 10.1007/BF00716378.